The results showed that most of the target genes were taking part in cancer-related pathways such as the cell cycle, apoptosis and signaling pathways including MAPK, p53, ErbB, Wnt, Jak-STAT and TGF-beta (Fig 2; p<0.0091). This evidence concerns the gene TP53 and cancer.